COMP <GO>
BLSM vs MNPR // GROSS PROFIT MARGIN
BlossomHill Therapeutics Inc. (NASDAQ) VS. Monopar Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: BLSM 2
— MNPR 0
■ METRIC PARITY
LAST: $15.21 (-7.59%) • MKT CAP: $483.4M
gross-margins
—
LAST: $71.91 (-2.02%) • MKT CAP: $482.7M
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLSM VS. MNPR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLSM | MNPR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -17.40% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -2.53% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 3/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.8 | 33.4 | +4.36 | BLSM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $483.4M | $482.7M | $776.2K | BLSM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLSM REV | MNPR REV | BLSM GROSS % | MNPR GROSS % | BLSM FCF | MNPR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | — | -$12.2M |
| FY 2024 | — | $0 | — | — | — | -$6.4M |
| FY 2023 | — | $0 | — | — | — | -$7.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLSM // BETA —
MNPR // BETA —